Skip to main content
HairCited

피나스테리드 그림

6 동료 심사 연구의 그림

전체 아연 철분 셀레늄 케라틴 콜라겐 카페인 (외용) 저준위 레이저 치료 미녹시딜 로즈마리 오일 두타스테리드 스피로노락톤 피나스테리드 마이크로니들링 오메가-3 지방산 비타민 B12 비타민 D L-시스테인 MSM PRP 치료
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1

Treatment options for androgenetic alopecia range from FDA-approved pharmacological agents (minoxidil and finasteride) to emerging therapies including low-level laser therapy, platelet-rich plasma, and hair transplantation. Efficacy, side effect profiles, and patient compliance vary substantially across modalities.

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and …

Fig. 5. Summary of evidence for the use of combination treatment of topical minoxidil in male and female androgenetic alopecia (Varothai and Bergfeld, 2014)
Figure 7

A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Figure 3
Figure 3

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 4
Figure 4

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Figure 5
Figure 5

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.
Figure 6

Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.

Epidemiological landscape of androgenetic alopecia in the US: An All of Us …